What condition leads to an unreasonable pharmaceutical price? impact research on the effect of medical service provision on pharmaceutical price regulation based on fuss-set qca

HIGHLIGHTS

• who: Lingzhi Brian Fang and collaborators from the School of Journalism, Fudan University, Shanghai, China, School of Management, Fudan University have published the Article: What condition leads to an unreasonable pharmaceutical price? Impact research on the effect of medical service provision on pharmaceutical price regulation based on fuss-set QCA, in the Journal: PLOS ONE of August/19,/2022
• what: Toward ensuring that pharmaceutical price regulation is efficient this study investigated the antecedents that lead to an unreasonable pharmaceutical price. The authors aim to detect the relationship between medical service provision and unreasonable pharmaceutical prices . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.